NaturalNano Key Patent for the Process to Use Halloysite Nanotubes for Nanocomposites Including Heat-Treated Clay and Polymer is Allowed by the USPTA


ROCHESTER, N.Y., June 21, 2012 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAND) announced that the US Patent & Trademark Office has allowed the Company a patent which claims protection for the process for the use of Halloysite Nanotubes (HNT) in the creation of Nanocomposites including Heat-Treated Clay and Polymers.

NaturalNano's CEO James Wemett commented, "We continue our efforts to expand and protect the uses of HNT as we explore new commercial applications. The claims allowed for this patent will cover NNAN's processes for utilizing HNT in nanocomposites including heat treated clay and polymers. This is the second NNAN patent application that has had its claims allowed in the last 30 days and strengthens NNAN's position as the world leader in the industrial applications for Halloysite. We continue to aggressively explore opportunities to expand commercial uses and licensing opportunities for HNT."

NaturalNano, Inc. (OTCBB:NNAND) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. http://www.naturalnano.com/">www.naturalnano.com

Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.



            

Contact Data